Craig Woods moderates the “The Whole Health Revolution” session

Dr. Craig Woods was invited to moderate the “Whole Health Revolution” panel at the 2025 AZAdvances Health Innovation Summit, held on October 16, 2025 at the ILUME Innovation Center in Scottsdale, Arizona. The panelists, pictured from left to right, were: Craig Woods DVM, MS, MBA: One Medicine Group, LLC and Woods Consulting, LLC (Animal Health … Read more

Dr. Woods Presents at AzVMA State Meeting

veterinary consultants

The Arizona Veterinary Medical Association invited Dr. Craig Woods to present “Comparative Medicine, advancing human and veterinary medicine in parallel” at the Arizona Veterinary Medical Association’s State Conference, held on June 18th, 2025 in Mesa, Arizona.  Dr. Woods provided a brief history of comparative medicine, One Medicine, and contemporary view of how veterinary clinical research is contributing to the advancement of human and veterinary medicine in parallel.  Dr. Woods emphasized the need to re-establish a One Medicine approach to overcome the deficits of laboratory research and accelerate the development of new biomedical innovations.  Dr. Woods is the founder of Animal Health Consultants (Woods Consulting, LLC) and One Medicine Group, LLC.  Dr. Woods is a biomedical consultant with extensive experience in managing human Phase II-III clinical trials, regulatory affairs, veterinary clinical research, and business development.  He is the former Director of Infectious Disease and Biosecurity Projects at Arizona State University’s Complex Adaptive Systems Initiative, where he worked on various projects including biological threat assessments for US Dept. of Defense, avian influenza biosurveillance, and human subjects research with Mayo Clinic Phoenix.  Prior to ASU, Craig was the Director of Midwestern University’s Institute for Healthcare Innovation with a joint appointment as the Director of Clinical Research for the Abrazo Health network. Prior to academia, Craig spent 17 years in pharmaceutical industry, working for companies in the US, Mexico, and France where he led due diligence and licensing negotiations for numerous drugs, biologics and medical devices. He received his BS, DVM, and MS from the University of Missouri and his MBA from Arizona State University.